News

December 30, 2009 – Medical device company Emerging Healthcare Solutions LLC (EHS) entered into an agreement to distribute ThromboVision’s T-Guide, a new diagnostic test to assess patient response...

December 22, 2009 – A new study is the first to specifically identify the year immediately around a woman’s final menstrual period as the time of most adverse changes in the lipid profile in women...

November 18, 2009 – Three platelet function tests identified patients who will have blood cells that remain sticky, increasing heart attack risk, despite being pretreated with two anti-clotting...

November 17, 2009 – Scientists have created a one-step, point-of-care diagnostic test based on a silicon chip that uses a smaller blood sample, is significantly faster, portable and easier to use...

November 17, 2009 – A new genetic test to detect familial dilated cardiomyopathy (DCM), the FAMILION DCM Test, was introduced this week at the 2009 American Heart Association (AHA) meeting in...

September 18, 2009 – Patients’ response to anti-platelet therapy after percutaneous coronary intervention (PCI) and its impact on clinical outcomes will be covered in a TCT 2009 breakfast...

August, 13, 2009 – Atherotech Inc. this week added two new cardiometabolic tests – the PLAC Test for identification of increased heart attack and stroke risk, and the Cystatin C test as an early,...

July 22, 2009 – Roche Diagnostics today introduced the Roche Cardiac 200, a comprehensive testing solution for rapid cardiac diagnostic needs in point-of-care testing environments.

May 10, 2009 - Biosite and the FDA notified healthcare professionals of the Class 1 recall of the Biosite brand Triage Cardiac Panel, a test is used by as an aid in the diagnosis of a heart attack...

April 9, 2009 - According to research presented last week at ACC, patients with the CYP2C19*2 genotype had more ischemic events in the one year following percutaneous coronary intervention (PCI...

March 20, 2009 - BRAHMS AG of Hennigsdorf, Germany and Annapolis, MD, recently submitted a 510(k) file to the FDA to market its patented BRAHMS MR-proANP Kryptor Test used to find biomarkers for...

February 19, 2009 - Molecular diagnostic company TrimGen Corp. has received FDA 510(k) clearance to market its eQ-PCR LC Warfarin Genotyping kit, an assay used to aid identification of patients...

August 28, 2008 - Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE),...

August 1, 2008 - Osmetech said this week at the American Association for Clinical Chemistry (AACC) 2008 Conference and Exhibition in Washington, D.C., that following receipt of its 510(k)...

July 22, 2008 - Osmetech today said it received FDA 510(k) clearance for its eSensor Warfarin Sensitivity Test to be used as an aid in the identification of patients at risk for increased...